A revolutionary process for treating horse arthritis
13 April 2016
Neuchâtel-based start-up Laserix, specialized in the treatment of early osteoarthritis in horses through its Cartilex laser, is now targeting the international market. Based at Neode technology park in Neuchâtel since its creation in 2006, Laserix has developed the Cartilex laser technique thanks to the scientific expertise of the University of Bern and the financial support […]
Neuchâtel-based start-up Laserix, specialized in the treatment of early osteoarthritis in horses through its Cartilex laser, is now targeting the international market.
Based at Neode technology park in Neuchâtel since its creation in 2006, Laserix has developed the Cartilex laser technique thanks to the scientific expertise of the University of Bern and the financial support of the Commission for Technology and Innovation (CTI). This revolutionary technology consists in removing only thin layers of damaged cartilage in order to restore the normal biomechanical functioning of the articulation and to stimulate the regeneration of hyaline cartilage.
Arthritis is one of the most common conditions that affect performance horses, some of whom are worth over 100,000 Swiss francs. Until recently, no cure was available. “Cartilex gives a second life to horses affected by osteoarthritis, which would otherwise be slaughtered or end up in pastures”, says Pierre Ravussin, founder of Laserix, in a press release. The first race horse treated with this revolutionary method in August 2014 has since won two races in 2015.
The start-up is now ready to conquer the global market, and is about to open reference centers at three veterinary clinics in France, where it was awarded the Hippolia label.